Biotricity Inc inventory turnover ratio, the Biotricity Inc 's ability to sell and replace its inventory in the third quarter 2025, sequentially increased to
1.47 in the third quarter 2024, yet the ratio remained below the average, as BTCY's market remain challenging.Average inventory processing period, for the Biotricity Inc in Dec 31 2024 quarter, has decreased to 248 days, compare to 270 days, in the Sep 30 2024 quarter.
Within
Healthcare sector 276 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2025, to
1620, from total ranking in the second quarter 2025 at
1695.
BTCY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Biotricity Inc Market Share?
What is Inventory Turnover Ratio?
| BTCY Inventory Turnover Ratio |
(Dec 31 2024)
III. Quarter |
(Sep 30 2024)
II. Quarter |
(Jun 30 2024)
I. Quarter |
(Mar 31 2024)
IV. Quarter |
(Dec 31 2023)
III. Quarter |
| Y / Y Inventory Growth |
-23.37 % |
-17.96 % |
-18.13 % |
-2.72 % |
10.54 % |
| Y / Y Cost of Sales Growth |
6.23 % |
-19.23 % |
-30.57 % |
-86.97 % |
-26.9 % |
| Inventory Turnover Ratio (TTM) |
1.47 |
1.35 |
1.38 |
1.49 |
1.91 |
| BTCY's Total
Ranking |
# 1620 |
# 1695 |
# 1363 |
# 1412 |
# 961 |
| Average inventory processing period |
248 |
270 |
264 |
246 |
191 |
| Seq. Inventory Growth |
-13.62 % |
-5 % |
1.8 % |
-8.27 % |
-7.52 % |
| Seq. Cost of Sales Growth |
5.88 % |
-3.69 % |
508.55 % |
-82.88 % |
-19.5 % |
| Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector | Inventory Turnover Ratio | Cost of revenues at quarter ending Dec 31 2024 | Inventories at quarter ending Dec 31 2024 |
| Novabay Pharmaceuticals Inc | 4.61 | $ 3.000 Millions | $ 1 Millions |
| Align Technology inc | 4.58 | $ 1,199.000 Millions | $ 262 Millions |
| Steris Plc | 4.50 | $ 3,053.916 Millions | $ 678 Millions |
| Acutus Medical Inc | 4.45 | $ 19.000 Millions | $ 4 Millions |
| Evolus Inc | 4.44 | $ 57.709 Millions | $ 13 Millions |
| Tarsus Pharmaceuticals Inc | 4.39 | $ 12.826 Millions | $ 3 Millions |
| Envista Holdings Corporation | 4.38 | $ 1,137.000 Millions | $ 259 Millions |
| Ufp Technologies Inc | 4.35 | $ 357.000 Millions | $ 82 Millions |
| Organogenesis Holdings Inc | 4.29 | $ 115.741 Millions | $ 27 Millions |
| Incyte Corporation | 4.25 | $ 312.068 Millions | $ 73 Millions |
| Vericel Corporation | 4.23 | $ 65.117 Millions | $ 15 Millions |
| Integrated Biopharma Inc | 4.21 | $ 47.000 Millions | $ 11 Millions |
| Adm Tronics Unlimited Inc | 4.19 | $ 1.728 Millions | $ 0 Millions |
| Precision Optics Corporation Inc | 4.12 | $ 13.612 Millions | $ 3 Millions |
| Ge Healthcare Technologies Inc | 4.10 | $ 8,271.000 Millions | $ 2,019 Millions |
| Waters Corporation | 4.07 | $ 1,406.115 Millions | $ 346 Millions |
| Abbvie Inc | 3.96 | $ 16,904.000 Millions | $ 4,274 Millions |
| Koru Medical Systems Inc | 3.95 | $ 12.315 Millions | $ 3 Millions |
| Idexx Laboratories Inc | 3.94 | $ 1,518.000 Millions | $ 386 Millions |
| Prophase Labs Inc | 3.90 | $ 12.408 Millions | $ 3 Millions |
| Electromed Inc | 3.84 | $ 13.825 Millions | $ 4 Millions |
| Logicmark Inc | 3.83 | $ 3.286 Millions | $ 1 Millions |
| Tactile Systems Technology Inc | 3.82 | $ 76.000 Millions | $ 20 Millions |
| Escalon Medical Corp | 3.80 | $ 6.401 Millions | $ 2 Millions |
| Mirum Pharmaceuticals Inc | 3.80 | $ 81.643 Millions | $ 22 Millions |
| Elutia Inc | 3.79 | $ 13.000 Millions | $ 3 Millions |
| Cadre Holdings inc | 3.77 | $ 337.870 Millions | $ 90 Millions |
| Inotiv Inc | 3.77 | $ 156.606 Millions | $ 42 Millions |
| Celularity Inc | 3.75 | $ 14.989 Millions | $ 4 Millions |
| Avanos Medical Inc | 3.73 | $ 587.500 Millions | $ 158 Millions |
